Evidence map›Paper›PMID 33484475›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.

Jean-Philip Truman, Christian F Ruiz, Magali Trayssac, Cungui Mao, Yusuf A Hannun, Lina M Obeid

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jean-Philip TrumanDepartment of Medicine, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0002-4496-590X
Christian F RuizDepartment of Genetics, School of Medicine, Yale University, New Haven, CT, USA.ORCID https://orcid.org/0000-0003-1470-8061
Magali TrayssacDepartment of Medicine, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0002-5572-3500
Cungui MaoDepartment of Medicine, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0002-1330-1887
Yusuf A HannunDepartment of Medicine, Stony Brook University, Stony Brook, NY, USA.ORCID https://orcid.org/0000-0003-3349-3369
Lina M ObeidDepartment of Medicine, Stony Brook University, Stony Brook, NY, USA.
Stony Brook University · USNorthport VA Medical Center · USYale University · US

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI YUSUF AWNI HANNUN · 2003 to 2026
$30.8M
Neutral Sphingomyelinases and Bioactive CeramidesR35GM118128 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2016 to 2025
$7.9M
Role for Sphingosine Kinase 1 in Serine DeprivationR01GM130878 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI MAO, CUNGUI · 2018 to 2020
$1.0M
HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM118128NCI NIH HHS P01 CA097132NIGMS NIH HHS R01 GM130878
6 · The paper itself

Abstract

It has been well-established that cancer cells often display altered metabolic profiles, and recent work has concentrated on how cancer cells adapt to serine removal. Serine can be either taken exogenously or synthesized from glucose, and its regulation forms an important mechanism for nutrient integration. One of the several important metabolic roles for serine is in the generation of bioactive sphingolipids since it is the main substrate for serine palmitoyltransferase, the initial and rate-limiting enzyme in the synthesis of sphingolipids. Previously, serine deprivation has been connected to the action of the tumor suppressor p53, and we have previously published on a role for p53 regulating sphingosine kinase 1 (SK1), an enzyme that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P). SK1 is a key enzyme in sphingolipid synthesis that functions in pro-survival and tumor-promoting pathways and whose expression is also often elevated in cancers. Here we show that SK1 was degraded during serine starvation in a time and dose-dependent manner, which led to sphingosine accumulation. This was independent of effects on p53 but required the action of the proteasome. Furthermore, we show that overexpression of SK1, to compensate for SK1 loss, was detrimental to cell growth under conditions of serine starvation, demonstrating that the suppression of SK1 under these conditions is adaptive. Mitochondrial oxygen consumption decreased in response to SK1 degradation, and this was accompanied by an increase in intracellular reactive oxygen species (ROS). Suppression of ROS with N-acteylcysteine resulted in suppression of the metabolic adaptations and in decreased cell growth under serine deprivation. The effects of SK1 suppression on ROS were mimicked by D-erythro-sphingosine, whereas S1P was ineffective, suggesting that the effects of loss of SK1 were due to the accumulation of its substrate sphingosine. This study reveals a new mechanism for regulating SK1 levels and a link of SK1 to serine starvation as well as mitochondrial function.

Indexed as

Adaptation, PhysiologicalProteolysisDown-RegulationHCT116 CellsHumansMitochondriaOxygenPhosphotransferases (Alcohol Group Acceptor)Proteasome Endopeptidase ComplexReactive Oxygen SpeciesSerineSphingosine KinaseTumor Suppressor Protein p53OxygenPhosphotransferases (Alcohol Group Acceptor)Proteasome Endopeptidase ComplexReactive Oxygen SpeciesSerineSphingosine KinaseTP53 protein, humanTumor Suppressor Protein p53serinesphingolipidssphingosinesphingosine kinase 1

Identifiers

PMID33484475
PMCPMC8272629
OpenAlexW3125324301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.